🔎 Trials Near Me

Почетна › Dijabetes tipa 2 › Јужна Каролина

Kliničke studije za Dijabetes tipa 2 u državi Јужна Каролина

19 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Јужна Каролина.

Gradovi u državi Јужна Каролина

Zvanični tekst studije (na engleskom)

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • PanAmerican Clinical Research - Bluffton, Bluffton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Piedmont Research Partners, LLC, Fort Mill
  • Velocity Clinical Research-Gaffney-69046, Gaffney
  • Tribe Clinical Research LLC - Greenville, Greenville
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Coastal Carolina Research Center, North Charleston
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Accellacare - Mt Pleasant, Mt. Pleasant
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Monroe Biomedical Research - Charleston, North Charleston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Myrtle Beach
  • Research Site, North Charleston
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

  • Monroe Biomedical Research, LLC, North Charleston
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT07668388

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Velocity Clinical Research, Anderson, Anderson
  • Accellacare Charleston, Mt. Pleasant
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Medical University of South Carolina, Charleston
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418

Improving the Collaborative Health of Adult Dyads

  • University of South Carolina, Columbia
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT05370014

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Bluffton
  • AURORA-2 Clinical Site, Clemson
  • AURORA-2 Clinical Site, Columbia
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

  • Research Site, Gaffney
  • Research Site, Greenville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Piedmont Research Partners, LLC, Fort Mill
  • Accellacare US Inc._SC, Mt. Pleasant
  • Trial Management Associates, Myrtle Beach
Тражи се учесникФаза 3
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  • Research Site, Anderson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 31. 8. 2026. · NCT07662044

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

  • Research Site, Gaffney
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 25. 8. 2026. · NCT07606066

Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls

  • Clemson Health Clinic at Orangeburg, Orangeburg
  • Clemson Health Clinic at Walhalla, Walhalla
Тражи се учесникОпсервациона студијаЗдраве особе су добродошлеНаводи исплату за учеснике
Узраст од 40 до 70 · Оба пола · Ажурирано 18. 8. 2026. · NCT07731399

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Prisma Health Pediatric Endocrinology, Columbia
  • Prisma Health Midlands, Greenville
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 7. 8. 2026. · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

  • Research Site, Myrtle Beach
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 8. 2026. · NCT07664553

CGM for Management of Type 2 Diabetes in Pregnancy

  • Prisma Health Greenville Memorial Hospital, Greenville
Тражи се учесник
Узраст од 18 до 50 · Жене · Ажурирано 29. 6. 2026. · NCT06628453

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.